肝脏激酶组图谱:深入鉴定人类与啮齿动物肝纤维化中的激酶通路
研究利用340个底物靶标、上游激酶通路生物信息学分析和超过2000次随机采样迭代的PamGene PamStation激酶组微阵列芯片技术,绘制了人类与啮齿动物肝纤维化的激酶通路图谱。在人类肝硬化和三种不同纤维化程度的鼠模型(包括两种脂肪肝病后纤维化模型)中比较纤维化事件,发现人与啮齿动物肝脏激酶组信号高度一致。胰岛素受体和盘状结构域受体酪氨酸激酶在纤维化中高度活跃。
要点
- 人类与啮齿动物肝纤维化激酶信号网络高度一致。
- 胰岛素受体在人类和啮齿动物纤维化肝病中高度活跃。
- 盘状结构域受体酪氨酸激酶在纤维化中活性升高。
核心结论
- 研究建立了肝纤维化的综合激酶图谱,鉴定出在人类与啮齿动物间保守的类似信号事件。
研究设计与样本
- 使用340个底物靶标、上游激酶通路生物信息学分析和超过2000次随机采样迭代的PamGene PamStation激酶组微阵列芯片技术,比较人类肝硬化和三种不同纤维化程度的鼠模型(包括两种脂肪肝病后纤维化模型)的肝纤维化激酶通路。
主要发现
- 胰岛素受体在人类和啮齿动物纤维化肝病中作为显著高度活跃的蛋白酪氨酸激酶出现。
- 盘状结构域受体酪氨酸激酶由纤维化中增加的胶原激活,是另一种在人类和啮齿动物纤维化中高度活跃的蛋白酪氨酸激酶。
- 在纤维化中最活跃的丝氨酸/苏氨酸激酶是肌营养不良蛋白1型激酶和蛋白激酶家族成员。
- 人类与啮齿动物肝脏激酶组信号高度一致,网络分析显示集中于有害通路。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Resolution of pathways that converge to induce deleterious effects in hepatic diseases, such as in the later stages, have potential antifibrotic effects that may improve outcomes. We aimed to explore whether humans and rodents display similar fibrotic signaling networks. APPROACH AND RESULTS: We assiduously mapped kinase pathways using 340 substrate targets, upstream bioinformatic analysis of kinase pathways, and over 2000 random sampling iterations using the PamGene PamStation kinome microarray chip technology. Using this technology, we characterized a large number of kinases with altered activity in liver fibrosis of both species. Gene expression and immunostaining analyses validated many of these kinases as bona fide signaling events. Surprisingly, the insulin receptor emerged as a considerable protein tyrosine kinase that is hyperactive in fibrotic liver disease in humans and rodents. Discoidin domain receptor tyrosine kinase, activated by collagen that increases during fibrosis, was another hyperactive protein tyrosine kinase in humans and rodents with fibrosis. The serine/threonine kinases found to be the most active in fibrosis were dystrophy type 1 protein kinase and members of the protein kinase family of kinases. We compared the fibrotic events over four models: humans with cirrhosis and three murine models with differing levels of fibrosis, including two models of fatty liver disease with emerging fibrosis. The data demonstrate a high concordance between human and rodent hepatic kinome signaling that focalizes, as shown by our network analysis of detrimental pathways. CONCLUSIONS: Our findings establish a comprehensive kinase atlas for liver fibrosis, which identifies analogous signaling events conserved among humans and rodents.
引用
- Creeden JF, Kipp ZA, Xu M, et al. Hepatic kinome atlas: An in-depth identification of kinase pathways in liver fibrosis of humans and rodents. Hepatology. 2022. PMID: 35313030. doi:10.1002/hep.32467
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。